Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study
about
Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a Cross-Sectional Observational StudyPhosphate binders in chronic kidney disease: a systematic review of recent data.Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infectionManagement of hyperphosphataemia in chronic kidney disease-challenges and solutionsFactors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patientsSevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease.Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.The role of phosphate in kidney disease.Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.Potassium supplementation and long-term outcomes in chronic peritoneal dialysis patients with end-stage renal disease: a propensity score matching study.The effect of omega-3 on serum lipid profile in hemodialysis patientsGastrointestinal complications induced by sevelamer crystals.Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.
P2860
Q28535870-CF2DAE96-EA2D-4A3F-ADD4-4E46B1F0C820Q31039292-B0FF44F2-05E8-41AC-A4A0-34ACD8F225DEQ34430215-27C35ACE-CB42-48AB-8146-842ACF47385CQ35608435-2AD61997-243F-45B1-AC26-7108A3D8F0C4Q35967669-DD891197-4C36-4FFA-8785-FF6F3D2BA150Q38210438-6D40D82F-DD8B-449D-9375-FE9A91C5B8EFQ38231646-0F1FE5CA-3F68-4997-B4AB-508AE410BB7EQ38793054-EA8AB5B2-3655-47B1-9194-6555DB8CDC5CQ39220825-88F2FB15-3158-46F0-BB47-98D8D2E7FCB3Q40521456-736D5D5B-E0C9-43B9-BFE0-68F81A11DDE4Q41300518-95A487BE-2D7D-4A6F-86DE-2C3730A64B9AQ41510628-116EEE34-FBD8-405A-B58C-0AECCF04FF2CQ49846193-FA99FBA4-A4B3-49CC-B147-936E5A2EAECE
P2860
Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2012
@uk
name
Effects of sevelamer hydrochlo ...... ty-matched observational study
@en
Effects of sevelamer hydrochlo ...... ty-matched observational study
@nl
type
label
Effects of sevelamer hydrochlo ...... ty-matched observational study
@en
Effects of sevelamer hydrochlo ...... ty-matched observational study
@nl
prefLabel
Effects of sevelamer hydrochlo ...... ty-matched observational study
@en
Effects of sevelamer hydrochlo ...... ty-matched observational study
@nl
P2093
P2860
P1476
Effects of sevelamer hydrochlo ...... ty-matched observational study
@en
P2093
Junichi Ishigami
Masato Tajima
Michio Kuwahara
Satomi Shikuma
Sei Sasaki
Shigeru Takada
Soichiro Iimori
Tamaki Kuyama
Tomokazu Okado
Tomoki Asai
P2860
P2888
P356
10.1007/S10157-012-0640-4
P407
P577
2012-12-01T00:00:00Z